Prostate cancer is one of the most common cancers in men, but early detection significantly improves treatment outcomes. Prostate cancer screening is an important part of men’s health, particularly for those over the age of 50 or those with a family history of the disease.
The most widely used test is the prostate-specific antigen (PSA) blood test, which measures PSA levels in the bloodstream. Elevated PSA levels may indicate cancer, but they can also result from benign conditions such as infection or enlarged prostate. That’s why results are always interpreted alongside a physical exam and other diagnostic tools.
A digital rectal exam (DRE) is another common screening method. During this exam, a doctor checks the prostate gland for lumps or irregularities. While it may feel uncomfortable, it is a quick and important step in identifying abnormalities.
For men with abnormal results, advanced imaging such as MRI and fusion-guided biopsy may be recommended. These technologies improve accuracy by targeting suspicious areas rather than relying on random sampling. The UroNav fusion biopsy, for example, combines MRI and ultrasound images for a more precise diagnosis.
Screening is not a one-size-fits-all process. Men with risk factors, including African American men and those with close relatives who had prostate cancer, may need to begin testing earlier than others. Decisions about when to start and how often to screen should always be made in partnership with a healthcare provider.
Regular prostate cancer screening is not about creating fear but about ensuring peace of mind and catching disease at its earliest, most treatable stage.
If you are due for prostate cancer screening, talk with our urologist today to create a plan that fits your age, risk level, and long-term health goals.
Quick Links
